Solazyme (SZEN) Files $100M IPO
Tweet
Share
E-mail
Solazyme, Inc. (Nasdaq: SZEM) filed a registration statement with the U.S. Securities and Exchange Commission today for an Initial Public Offering of their Common Stock. The proposed maximum aggregate offering price is $100 million. The company has filed to list their shares on Nasdaq Capital Markets under the ticker "SZEM."
Te offering is being made through Morgan Stanley, Goldman Sachs, Pacific Crest Securities, and Lazard Capital Markets.
Solazyme makes oil. Specifically, SZEM transforms a range of low-cost plant-based sugars into high-value oils.
Te offering is being made through Morgan Stanley, Goldman Sachs, Pacific Crest Securities, and Lazard Capital Markets.
Solazyme makes oil. Specifically, SZEM transforms a range of low-cost plant-based sugars into high-value oils.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PureCycle launches $250M convertible notes and $145M stock offerings
- EquipmentShare adds two directors to board following IPO completion
- IDEAYA Biosciences closes $345 million public offering
Create E-mail Alert Related Categories
IPOsRelated Entities
Morgan Stanley, Lazard, Pacific Crest SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
